Newsletters
ePaper
My Account
Home
Elections
India
Karnataka
Opinion
World
Business
Sports
Entertainment
Video
IPL
News Shots
Explainers
Bengaluru
Science
Trending
Brandspot
Photos
Newsletters
Home
News Shots
Trending
Menu
×
ADVERTISEMENT
ADVERTISEMENT
AstraZeneca
Covid-19 | Families grappling with vaccine-related fatalities deserve answers and support
It is essential to remember that every individual impacted by vaccine-related issues deserves to have their concerns heard and addressed with empathy and fairness
02 May 2024, 05:28 IST
Covid-19 | Families grappling with vaccine-related fatalities deserve answers and support
02 May 2024, 05:28 IST
Covishield row: Gujarat Congress demands compensation, BJP claims heart attacks not linked to vaccine
Doctors associated with the Gujarat BJP, however, said a study by an expert panel in the state had established that there was no direct link between COVID-19 vaccines and blood clotting which can lead to heart attacks.
01 May 2024, 19:21 IST
Covishield row: Gujarat Congress demands compensation, BJP claims heart attacks not linked to vaccine
01 May 2024, 19:21 IST
Plea in SC seeking expert panel to examine possible side effects, risk factors of Covishield vaccine
The application, also sought a direction to the Centre to compensate those who are severely disabled or have died because of any side effects of the vaccine.
01 May 2024, 13:54 IST
Plea in SC seeking expert panel to examine possible side effects, risk factors of Covishield vaccine
01 May 2024, 13:54 IST
Covishield developer AstraZeneca extends 'sympathies' amid vaccine side-effect concerns
'Our sympathy goes out to anyone who has lost loved ones or reported health problems. Patient safety is our highest priority, and regulatory authorities have clear and stringent standards to ensure the safe use of all medicines, including vaccines,' AstraZeneca said in a statement.
01 May 2024, 06:28 IST
Covishield developer AstraZeneca extends 'sympathies' amid vaccine side-effect concerns
01 May 2024, 06:28 IST
Covishield developer AstraZeneca admits its vaccine can cause side effects in 'very rare cases'
Such cases have been reported since early 2021 from Denmark, the UK, Germany and Canada and, on August 11, the UN had issued guidelines for diagnosis and management of TTS.
30 April 2024, 05:29 IST
Covishield developer AstraZeneca admits its vaccine can cause side effects in 'very rare cases'
30 April 2024, 05:29 IST
AstraZeneca to buy China-based Gracell Biotechnologies for $1.2 billion
The cash deal aimed at bolstering AstraZeneca's portfolio values US-listed Gracell at $2 per ordinary share or $10 per ADS of Gracell, plus a non-tradable contingent value right of $0.30 per ordinary share, if certain regulatory milestones are met.
26 December 2023, 09:38 IST
AstraZeneca to buy China-based Gracell Biotechnologies for $1.2 billion
26 December 2023, 09:38 IST
AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bn deal
The deal, which aims to target the multi-billion RSV market, also comes at a time when AstraZeneca has seen sales of ots Covid-19 vaccine almost evaporate post pandemic.
12 December 2023, 11:10 IST
AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bn deal
12 December 2023, 11:10 IST
AstraZeneca commits $71 million to Meghalaya's forestry project
The funding is part of its global forest programme, under which it has committed to plant 200 million trees across six continents by 2030, the company said in a statement on Monday.
04 December 2023, 18:15 IST
AstraZeneca commits $71 million to Meghalaya's forestry project
04 December 2023, 18:15 IST
AstraZeneca, AI biologics firm Absci tie up on cancer drug
The collaboration aims to harness Absci's AI technology for large-scale protein analysis to find a viable oncology therapy, a leading focus of AstraZeneca, the report said. It did not say what kind of cancer they plan to target.
03 December 2023, 06:54 IST
AstraZeneca, AI biologics firm Absci tie up on cancer drug
03 December 2023, 06:54 IST
K'taka govt joins hands with AstraZeneca to deploy AI-based lung cancer screening technology
This AI-powered chest X-ray system developed by health-tech startup 'Qure.ai' will help the government detect lung nodules, often precursors to lung cancer, in 19 district hospitals in Karnataka, overcoming a major early detection challenge, officials said.
12 October 2023, 14:06 IST
K'taka govt joins hands with AstraZeneca to deploy AI-based lung cancer screening technology
12 October 2023, 14:06 IST
<
1
2
...
75
>